Phase I Units
The facilities you need to make rapid “go/no-go” decisions.
Gain the critical data needed to make earlier, more confident decisions. Leave it to us to manage the complexity of Phase I trials in healthy volunteers, patients and special populations with our global network of clinical research units (CRUs).
A network of support
Drive your clinical research with our state-of-the-art CRUs backed up by a network of specialist site partners.
Get essential expertise
Leverage our in-house know-how as we manage the complexity of studies, react quickly to incoming data and speed toward an informed go/no-go decision.
On-site cGMP
Our on-site cGMP pharmacies simplify drug formulation and delivery.
| CRU Location | Madison, WI | Daytona Beach, FL | Dallas, TX | Leeds, UK | San Antonio, TX |
|---|---|---|---|---|---|
| Number of beds | 88 beds | 88 beds | 100 beds | 100 beds | 200 beds |
| Size | 42,000 ft2 (3,900m2) | 40,000 ft2 (3,700m2) | 55,000 ft2 (5,100m2) | 65,000 ft2 (6,000m2) | 60,000 ft2 (5,574m2) |
| cGMP Pharmacy | |||||
| Radiolabeled hAME studies |
| ||||
| Clinspark® BDC | |||||
| Asian ethno-bridging studies | |||||
| High visibility beds for monitoring1 | 30 | 36 | |||
| ECG and telemetry holter monitoring | |||||
| Fibroscan | |||||
| Ophthalmology suite | |||||
| Dedicated screening area | |||||
| Psychedelics | |||||
| Specialized procedures | Bile collection | CSF Collection, PBMCs, Bioimpedance Analysis, Local imaging (DEXA, MRI, Ultrasound) | Muscle Biopsy | Human appetite lab, CSF collection2, skin & muscle biopsies, PBMC collection and preparation | Muscle Biopsy |
1. High visibility beds are included in the total bed number count
2. Leeds, UK CSF collection (indwelling cannula or individual samples)
Clinspark® is a registered trademark of IQVIA Inc.
Managing complexity is our specialty
Advance your Phase I trial at one of our four CRUs strategically based in the U.S. and the U.K. These state-of-the-art facilities provide everything you need to advance complex research while promoting participant well-being.
Leeds, U.K.
Our sustainably designed CRU in Leeds Drapers Yard combines our two former locations with 100 beds, a cGMP pharmacy, including two sterile and two nonsterile rooms, and increased capacity for ECG and telemetry Holter monitoring.
Daytona Beach, Florida
Encompassing an estimated population of more than 21 million people, our Daytona Beach CRU boasts a track record of delivering on a range of trials spanning FIH bioequivalence, bioavailability, definitive QTc, drug-drug interaction, proof-of-concept, rising dose and Phase IIa patient studies.
Madison, Wisconsin
Our Madison CRU is regarded as the global leader in the conduct of radiolabeled clinical studies. The site also includes a cGMP pharmacy, including two sterile and three nonsterile manufacturing suites.
Dallas, Texas
Fortrea’s CRU in Dallas, Texas, is a purpose-built facility designed to support the complexities of early-phase clinical trials. The site features an on-site cGMP pharmacy, dedicated ophthalmology procedure rooms, screening and outpatient areas, and advanced telemetry. With a 100-bed capacity and more than 25 years of research experience, it is one of four dedicated Fortrea CRUs and plays an important role in supporting the company’s early-stage clinical research capabilities.
San Antonio, Texas
Fortrea’s CRU in San Antonio, Texas, is a purpose-built facility designed to support the complexities of early-phase clinical trials. The site features a 200-bed, GCP-compliant clinical pharmacology unit with capabilities for participant recruitment, domiciling, and the conduct of Phase I studies. As one of Fortrea’s dedicated early development facilities, the San Antonio CRU expands the company’s capacity to support a wide range of clinical pharmacology programs and provides access to diverse participants and patient populations.
The team had excellent communication and knowledge about what was always needed during the course of the study, and they were able to adapt to timelines as changes occurred.
Large Pharma
They were able to adapt to timelines.
Insights